MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05782-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Xin Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Disease Progression, Liver Neoplasms, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Henan Province Medical Science and Technology Research Plan, The Medical Science and Technology Program of Henan.
Abstract (Originalsprache)
Background
Human MARCH5 is a mitochondria-localized E3 ubiquitin-protein ligase that is essential for the regulation of mitochondrial dynamics. A large body of evidence suggests that imbalances in mitochondrial dynamics are strongly associated with cancer. However, the expression, biological function and prognostic significance of MARCH5 in hepatocellular carcinoma (HCC) have not been determined. Materials and methods The mRNA and protein expression of MARCH5 in HCC cell lines and tumor tissues was assessed by real-time quantitative PCR, Western blot analysis and immunohistochemistry. The clinical prognostic significance of MARCH5 was evaluated in 135 HCC patients. Knockdown or overexpression of MARCH5 in HCC cells was determined by in vitro cell proliferation, migration and invasion assays, and in vivo tumor growth and metastasis assays. In addition, the intrinsic mechanisms by which MARCH5 regulates HCC cell growth and metastasis were explored.
Results
MARCH5 was significantly overexpressed in HCC cells and was closely associated with patients' poor postoperative prognosis. In vivo and in vitro experiments revealed that MARCH5 significantly promoted the increase and invasive and migratory ability of hepatocellular carcinoma cells, which was mainly due to the promotion of autophagy by MARCH5. Mechanistic studies revealed that MARCH5 promoted autophagy through ubiquitination degradation of p53 leading to malignant progression of hepatocellular carcinoma.
Conclusion
Our findings suggest that MARCH5 plays a critical oncogenic role in HCC cells, which provides experimental evidence for the use of MARCH5 as a potential target for HCC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Henan Liver Transplantation Centre, Zhengzhou, China.
- The Main Construction Unit of National Regional Medical Center for Henan Organ Transplantation, Zhengzhou, China.
- Henan Research & Development International Joint Laboratory for Organ Transplantation Immunomodulation, Zhengzhou, China.
- Zhengzhou Key Laboratory for Hepatobiliary & Pancreatic Diseases and Organ Transplantation, Zhengzhou, China.
- Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Zhangshuijun@zzu.edu.cn.
Förderung
- the National Natural Science Foundation of China
- the Henan Province Medical Science and Technology Research Plan
- The Medical Science and Technology Program of Henan
Zitieren
APA
Cai, X., Gao, J., Yan, Z., Zhang, H., Guo, D., & Zhang, S. (2024). MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05782-7
Vancouver
Cai X, Gao J, Yan Z, Zhang H, Guo D, Zhang S. MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05782-7
BibTeX
@article{Cai2024,
author = {Cai, Xin and Gao, Jie and Yan, Zhiping and Zhang, Huapeng and Guo, Danfeng and Zhang, Shuijun},
title = {MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05782-7}
}
EUVIMED